Fundraising Fox

SciNeuro Pharmaceuticals

1 known investors

scineuro.com ↗

SciNeuro develops targeted therapeutics for neurodegenerative and age-related brain diseases by integrating patient genetics, health history, and advanced diagnostic tools. The company collaborates with scientific institutions to create disease-modifying therapies addressing aging populations' neurological challenges.

BiotechDeep TechDigital HealthLongevityMedical Devices

Founders & leadership

ML
Min LiCEO & Director
SA
Sam AgusCSO/CMO
PS
Paul SteadCBO

Investors · 1

ARCH Venture PartnersChicago

In the news